Game Plan Financial Advisors, LLC Mesoblast LTD Transaction History

Game Plan Financial Advisors, LLC

  • $180 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.17 - $7.09 $90,072 - $153,144
-21,600 Closed
0 $0
Q3 2021

Oct 26, 2021
SELL
$5.87 - $7.85 $5,283 - $7,065
-900 Reduced 4.0%
21,600 $130,000
Q2 2021

Jul 14, 2021
BUY
$6.69 - $9.0 $16,725 - $22,500
2,500 Added 12.5%
22,500 $168,000
Q1 2021

Apr 28, 2021
BUY
$8.26 - $11.4 $24,780 - $34,200
3,000 Added 17.65%
20,000 $164,000
Q4 2020

Jan 19, 2021
BUY
$8.21 - $18.59 $139,570 - $316,030
17,000 New
17,000 $141,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Game Plan Financial Advisors, LLC Portfolio

Follow Game Plan Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email